A non-interventional study assessing Quality of life and clinical outcomes in metastatic colorectal cancer patients treated with FOLFIRI and aflibercept in Germany, Switzerland, and Austria (GSA): QoLiTrap-study

Trial Profile

A non-interventional study assessing Quality of life and clinical outcomes in metastatic colorectal cancer patients treated with FOLFIRI and aflibercept in Germany, Switzerland, and Austria (GSA): QoLiTrap-study

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Apr 2016

At a glance

  • Drugs Aflibercept (Primary) ; Fluorouracil; Folinic acid; Irinotecan
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Apr 2016 New trial record
    • 23 Jan 2016 Interim results (n=277) presented at the 2016 Gastrointestinal Cancers Symposium
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top